Axon is the GP selected to lead VentureEU, a Programme launched by the European Commission and the European Investment Fund that will attract €2.1 billion into the European Venture Capital market, b...
With the backing of the European Investment Fund (EIF) and other institutional investors, Aurora, Axon’s a Fund-of-VC-Fund for Europe will invest across the Pan-European region, allowing more than 5...
3i Group plc (“3i”) today announces the final close of the 3i European Operational Projects Fund (“3i EOPF”), with €456 million of commitments received from European and Asian investors, inc...
Altamar Global Secondaries IX, como ha sido bautizado el nuevo vehículo de la gestora, le ha valido a la entidad española un hueco entre los cinco fondos recompradores más grandes del planeta cerra...
Potential exits featured strongly in a couple of Africa's private capital deal stories last week. And there was talk of a merger of the operations of two telcos as a first step toward an outright acqu...
Según el estudio, las 138 empresas que han sido respaldadas por Sodena en este periodo han aumentado su empleo directo en un 90% -2.509 empleos en números absolutos-, y han multiplicado sus ventas p...
Agribusiness and Tech led the way in Africa's private capital deal world last week. EXEO Capital, the partnership established by Agri-Vie and Sanlam, is investing in the Marginpar Flower Group in tand...
The shareholders supported the accounts of the company, accounts which show that the committed portfolio of investments managed by COFIDES reached the amount of 1,051.77 million euro. In addition to t...
Revenues increased by +11.3%, up to €26.6mn, driven by a +14.5% revenue growth in Investment Banking and a +6.6% increase in Asset Management. No performance fees were generated during the quarter.
Deal types and sizes related to Africa's private capital markets varied widely last week. At the high end, a couple of IPO-related items hogged the limelight. Towards the lower end, venture investment...
El nuevo fondo se va a enfocar en la toma de participaciones, habitualmente mayoritarias , en compañías rentables y en crecimiento de tamaño pequeño y medio con EBITDA entre 1 y 5 millones de euro...
